Epidemilogic features of mediterranean spotted fever in Portugal;Sobre a realidade da febre escaro-nodular em Portugal

Acta Medica Portuguesa

Volumn 16, Issue 6, 2003, Pages 429-436

  De Sousa, Rita ^a   Nóbrega, Sónia Dória ^a   Bacellar, Fátima ^a   Torgal, Jorge ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Incidence; Mediterranean spotted fever; Mortality; Rickettsia conorii

Indexed keywords

CLARITHROMYCIN; COTRIMOXAZOLE; JOSAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BOUTONNEUSE FEVER; DISEASE CARRIER; EPIDEMIOLOGICAL DATA; FEVER; HUMAN; INCIDENCE; LETHALITY; MORTALITY; NONHUMAN; PORTUGAL; RASH; RHIPICEPHALUS SANGUINEUS; RICKETTSIA CONORII; RICKETTSIOSIS; TICK BORNE DISEASE; VASCULITIS;

ADOLESCENT; ADULT; AGED; BOUTONNEUSE FEVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PORTUGAL;

EID: 9644301041     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. RAOULT D, ROUX V: Rickettsiosis as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10: 694-719
2. DGCSP - Serviço de Informação de Saúde. Doenças de Declaração obrigatória 1989-1998 Ministério da Saúde, Direcção Geral da Saúde, Lisboa, Portugal
3. JORGE R: La fièvre exanthématique (fièvre escharo-nodulaire) et son apparition au Portugal. Lisboa Médica 1930; 74: 33-454.
4. OLIVEIRA J, CÔRTE-REAL R: Rickettsioses em Portugal. Acta Médica Portuguesa 1999; 12: 313-321
5. ANDERSON DR, HOPPS HE, BARILE MF, BERNHEIM BC: Comparison of the ultrastructure of several rickettsiae, ornithosis virus, and Mycoplasma in tissue culture. J Bacteriol 1965; 90: 1387-1404
6. WEISS E: Growth and phisiology of Rickettsiae. Bacteriol Rev 1973; 37(3): 259-283
7. WEISS E, MOULDER JW, ORDER I. RICKETTSIALES. In: N. R. Krieg and J. G. Holt, editors. Bergey's Mannual of systematic Bacteriology Baltimore: Williams and Wilkins 1984: 711-717
8. FOURNIER PE, ROUX V, RAOULT D: Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rompA. Int J Sist Bacteriol 1998; 48: 839-849
9. BACELLAR FC, BEATI L, FRANÇA A, POÇAS J, REGNERY R, FILIPE AR: Israeli spotted fever Rickettsia (Rickettsia conorii complex) associated with humam diseses in Portugal. Emerg Infect Dis 1999; 5(6): 835-836
10. GOLDWASSER RA, KLINGBERG W, STEIMAN Y, SWARTZ TA: The Isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from another members of the group by immunofluorescence methods. Scand J Infect Dis 1974; 6: 53-62
11. AHARONOWITZ G, KOTON S, SEGAL S, ANIS E, GREEN MS. Epidemiological Characteristics of Spotted Fever in Israel Over 26 Years. Clin Infect Dis 1999; 29: 1321-2
12. REHACEK J, TARASEVICH IV: Acari- Borne Rickettsiae & Rickettsioses in Euroasia. Veda publishing House. Bratislava. 1988; 1: 1-343
13. Kazar and Toman editors: Spotted fever group rickettsiae. Proceedings of Vth International symposium on: Rickettsiae and Rickettsial Diseases: 1996 Sep; Brastislava. Bratislava: Slovak Academy of Sciences 1996
14. CAEIRO V: As Carraças em Portugal: Seus Hospedeiros Domésticos e Silvestres Ciclos Vitais, Preferências de Vegetação e de Clima. Med Vet 1992; 28: 7-25
15. SOUSA R: Sobre a realidade epidemiológica da febre escaro-nodular. factores de risco de Morrer em doentes do distrito de Beja (dissertaç ão) Lisboa. Universidade Nova de Lisboa, 2002
16. GILOT B, LAFORGE ML, PICHOT J, RAOULT D: Relationships Between the Rhipicephalus sanguineus Complex Ecology and Mediterranean Spotted Fever Epidemiology in France. Eur J Epidemiol 1990; 6(4): 357-362
17. DUPONT HT, RAOULT D: Épidémiologie de la Fièvre Boutonneuse Mediterranéenne en France. Med Mal Infect 1992; 23; 485-490
18. HERRERO-HERRERO JI, RUIZ-BELTRÁN R, MARTÍN-SANCHEZ AM, GARCIA EJ. Mediterranean Spotted Fever in Salamanca, Spain. Epidemiological Study in Patients and Serosurvey in Animals and Healthy Human Population. Acta Trop 1989; 46: 335-350
19. WALKER DH, FISHBEIN DB: Epidemiology of Rickettsial diseases. Eur J Epidemiol 1991; 7: 237-245
20. WALKER DH, MATTERN WD: Rickettsial vasculitis. Am Heart J 1980; 100: 896-906
21. CARMO G, CAIXEIRO IS, UVA AS, PAIVA JD: Febre Escaro-Nodular. Actualização Teórica e Análise Retrospectiva de 231 Casos. Rev Port Doenças Infecciosas 1981; 4(1): 13-28
22. MALTEZ F, MACHADO J, MORGADO A, PROENÇA R: Febre escaro-nodular: Casuística de 10 anos (1977-1986). Estudo clínico- epidemiológico de 247 casos. O Médico 1989; 120: 459-464
23. RIBEIRO A, PEREIRA AA, CARMONA H, BOAVENTURA JL: Febre escaro-nodular: Doença benigna? Rev Port Doenças Infecciosas 1999; 1(22): 17-21
24. MORAIS JA, BACELLAR F, FRANCA S, FILIPE AR, AZEVEDO F: Isolamento e caracterização de Rickettsia conorii num caso clínico fulminante, sem escara de inoculação nem exantema. Rev Port Doenças Infecciosas, 1996; 1-2: 110-116
25. YAGUPSKY P, WOLACH B: Fatal Israeli spotted fever in children. Clin Infect Dis 1993; 17: 850-853
26. GROSS EM, YAGUPSKY P: Israeli rickettsial spotted fever in Children. A review of 54 cases. Acta Trop 1987; 44: 91-96
27. REGEV-YOCHAY G, SEGAL E, RUBINSTEIN, E. Glucose-6-phosphate Dehydrogenase Deficiency: Possible Determinant for a Fulminant Course of Israeli Spotted Fever. IMAJ 2000; 2: 781-782
28. PRICE WH: A quantitative analysis of the factors involved in the variations in virulence of rickettsiae. Science 1953; 118: 49-52
29. MCDADE, JE: Evidence supporting the hypothesis that rickettsial virulence factors determine the severity of spotted fever and typhus group infections. Ann N Y Acad Sci 1990; 590: 20-6
30. KEMPER C A, SPIVACK A P, DERESINSKI, SC: Atypical papulovesicular rash due to infection with Rickettsia conorii. Clin Infec Dis 1992; 15: 591-594
31. SEXTON J, COREY GR: Rocky mountain "Spotless" and "Almost spotless" Fever: A wolf in Sheep's clothing. Clin Infect Dis 1992; 15: 439-48
32. KIRKLAND BK, WILKINSON WE, SEXTON DJ: Therapeutic Delay and Mortality in Cases of Rocky Mountain Spotted Fever. Clin Infec Dis 1995; 20: 1118-21
33. Lancet (editorial). Bitten, hot, and mostly spotty. Lancet 1991; 337: 143-144
34. DALTON MJ, CLARCK MJ, HOLMAN RC, KREBS JW, FISHBEIN DB, OLSON JG, CHILDS JE: National surveillance for Rocky Mountain Spotted Fever, 1981-1992: Epidemiologic Summary and Evaluation of Risk Factors For Fatal Outcome. Am J Trop Med Hyg 1995; 52(5): 405-413
35. RAOULT D, ZUCHELLI P, WEILLER P, SAN MARCO J, GALLAIS H, CASANOVA P: Incidence, clinical observations and risk factors in the severe form of mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. J Infect Dis 1986; 12: 111-116
36. WEIL E, FELIX A: Zur Serologischen Diagnose des Fleckfiebers. Wiener Klinische Wochenschrift 1916; 29(2): 33-35
37. RAOULT D, DASH G: Immunoblot cross-reactions among Rickettsia, Proteus spp. and Legionella spp. In Patients with Mediterranean spotted fever. FEMS Immunol Med Microbiol 1995; 11: 13-18
38. BACELLAR FC, FILIPE AE: Actuais metodologias aplicadas no diagnóstico laboratorial de rickettsioses. Rev Port Doenç Infec (Aceite para publicação)
39. RAOULT D, ROUSSEAU B, TOGA B, GALLAIS P, DE MICO AND CASANOVA P: Serological Diagnosis of Mediterranean boutonneuse fever. Pathol Biol 1984; 32: 791-794
40. WHO/OMS. Laboratory diagnosis of Rickettsial Diseases. Bull WHO 1988; 66(3): 283-420
41. NEVES C: Sobre a Febre escaro-nodular. Med Comtemp 1932; 50(39): 295-296
42. CUTILEIRO J: Considerações Acerca do Tratamento das Rickettioses Exantemáticas pela Aureomicina. J Soc Cienc Med Lisboa 1950; 114(5): 179-192
43. GAC P, ARQUIE, E: Considerations epidemiologiques sur la fievre exanthematique boutonneuse mediterraneenne deuxieme note. Bul Soc Pathologie Exotique 1966; 59(6): 949-953
44. NINA C: Terramicina no tratamento da febre escaro-nodular. Bol Clin Hosp Civis Lisboa 1951; 15: 720-729
45. RAOULT D, P. ROUSSELLIER, TAMALET: In vitro-evaluation of Josammycin, spiramycin and erythromycin against Rickettsia rickettsii, and R. conorii. Antimicrob Chemother 1988; 32: 255-256
46. JABARIT-ALDIGHIERI N, TORRES H, RAOULT D: Susceptibility of Rickettsia conorii, R.rickettsii, and Coxiella burnety to CI960 (PD 127,391), PD 131,628, pefloxacin, ofloxacin and ciprofloxacin. Antimicrob Agents Chemother. 1992; 36: 2529-2532
47. MAURIN M, RAOULT D: Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, "Israeli spotted fever group rickettsia" and "Caxiella burnettii. J. Antimicrob. Chemother 1997; 39: 725-730
48. BOURGEADE A, PASTOR MI, RAOULT D: Notes sur la fievre boutonneuse méditerranéenne (a propos de 40 cas recents a Marseille) Bull Soc Path Exot 1979; 72: 308-314
49. MARCOS F, TURABIAN JL, MOREIRAS JI, GORGOLAS P, DURAN A: Fiebre botonosa mediterránea. Trimetoprim-sulfametoxazol tratamiento de elección Med Clin 1983; 81: 236.
50. RAOULT D. Antibiotic susceptibility of Rickettsia and treatment of rickettsiosis. Eur J Epidemiol 1989; 5(4): 432-435
51. RUIZ BELTRAN R, HERRERO HERRERO JI: Deleterious effect of trimetrhoprim- sulfamethoxazol in Mediterranean Spotted Fever (letter). Antimicrob Agents Chemother 1992; 36: 1342-1344
52. RAOULTD AND BROUQUIP editors. Antimicrobial therapy of rickettsial diseases. In: Proceedings of International symposium on: Rickettsiae and Rickettsial Diseases at the turn of the third millenium. Marseille. ELSEVIER 1999
53. SOUSA R, NOGUEIRA P, PIRES H, FILIPE AR, TORGAL J: Mediterranean spotted fever in Portugal: Influence of climatic factors Conferência Internacional sobre alterações climáticas. Bases científicas e implicações económicas e politicas. Lisboa, 3-4 Novembre 2000
54. RAOULT D, TISSOL DUPONT H, CARACO P, BROUQUI P, DRANCOURT M, CHARREL C: Mediterranean Spotted Fever in Marseille: Descriptive Epidemiology and Climatic Factors Influence. Eur J Epidemiol 1992; 8(2): 192-197